Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new Revision: v3.6.4 replacing v3.6.3, indicating a small update to the page version. No substantive study details appear to be changed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a small page update rather than a substantive change to study details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page’s revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a backend/template update. This change does not modify the trial details, eligibility criteria, or outcomes shown on the page.SummaryDifference0.1%

- Check49 days agoChange Detected- Recruitment status updated to 'No longer looking for participants', signaling that the study is no longer recruiting. - New help/navigation entries (How to Read a Study Record, Common Questions, How to Join a Study) were added, the header formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision note at the bottom was updated from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check56 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new page version. There are no visible edits to study details or user-facing content described in this change.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This represents a small metadata update rather than substantive changes to the content.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.